tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ARTL Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
4d ago
ABIO
ALLO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5d ago
ARTL
ASLN
Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
PremiumPress Releases
Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
7d ago
ARTL
Artelo Biosciences receives FDA clearance of IND application for ART26.12
PremiumThe Fly
Artelo Biosciences receives FDA clearance of IND application for ART26.12
7d ago
ARTL
Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
PremiumPress Releases
Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
19d ago
ARTL
Artelo Biosciences announces presentations about ART12.11
PremiumThe FlyArtelo Biosciences announces presentations about ART12.11
19d ago
ARTL
Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform
PremiumPress Releases
Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform
20d ago
ARTL
Artelo Biosciences’ FABP inhibitor platform featured in three presentations
PremiumThe Fly
Artelo Biosciences’ FABP inhibitor platform featured in three presentations
20d ago
ARTL
Artelo Biosciences presents preclinical data on ART26.12
PremiumThe Fly
Artelo Biosciences presents preclinical data on ART26.12
21d ago
ARTL
Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium
PremiumPress Releases
Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium
21d ago
ARTL
Artelo Biosciences presents important new data on ART26.12
PremiumThe Fly
Artelo Biosciences presents important new data on ART26.12
2M ago
ARTL
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
PremiumPress Releases
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
2M ago
ARTL
Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24
PremiumPress ReleasesArtelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24
2M ago
ARTL
Artelo Biosciences presents data on solid dosage form of ART12.11 at CN-CANN24
PremiumThe Fly
Artelo Biosciences presents data on solid dosage form of ART12.11 at CN-CANN24
2M ago
ARTL
Artelo Biosciences reports Q1 EPS (78c) vs (76c) last year
PremiumThe Fly
Artelo Biosciences reports Q1 EPS (78c) vs (76c) last year
2M ago
ARTL
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
ARTL
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
PremiumPress Releases
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
2M ago
ARTL
Artelo Biosciences announces publication of peer-reviewed article on FABP7
PremiumThe Fly
Artelo Biosciences announces publication of peer-reviewed article on FABP7
3M ago
ARTL
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
PremiumPress Releases
Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
3M ago
ARTL
Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
PremiumPress ReleasesArtelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
3M ago
ARTL
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
PremiumPress Releases
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
4M ago
ARTL
Artelo Biosciences reports 2023 EPS ($3.14), consensus ($2.56)
PremiumThe Fly
Artelo Biosciences reports 2023 EPS ($3.14), consensus ($2.56)
4M ago
ARTL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >